Amgen Inc.AMGN

Is AMGN cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$460.73+8.90 (+1.97%)24:00 UTC
NASDAQHealthcare

Company snapshot

Market Cap
$251B
Mega-cap
+108%
2016 — today
10-Year Price
+189%
2016 — today
52-Week Range
$292.00$460.73
Current $460.73· 100%

Amgen (est. 1980, Thousand Oaks, CA) discovers, develops, and manufactures human therapeutics across oncology, hematology, inflammation, bone health, cardiovascular disease, nephrology, and neuroscience. Its portfolio includes Enbrel, Neulasta, Prolia, Xgeva, Otezla, Aranesp, KYPROLIS, and Repatha. Amgen distributes globally to healthcare providers via wholesalers and direct channels. The firm maintains strategic R&D alliances with partners including Novartis, UCB, BeiGene, and Eli Lilly to advance clinical pipelines.

Similar companies

Healthcare companies of comparable size to AMGN
CompanyP/EDiv yield
TMOThermo Fisher Scientific Inc.37.40.3%
AZNAstraZeneca PLC26.21.9%
GILDGilead Sciences, Inc.-52.42.0%
NVSNovartis AG30.72.9%
ABTAbbott Laboratories38.72.4%
MRKMerck & Co., Inc.117.12.3%
NVONovo Nordisk A/S10.04.6%
PFEPfizer Inc.39.65.7%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
28.6
Historically pricey
Historically pricey — last 10 years
Sector median 25.2above sector
P/B ratio
21.4
Above average
Pricier than usual over the last 10 years
Sector median 2.2above sector
EV / EBITDA
16.7
Near historic high
Near historic highs — last 10 years
Sector median 15.4in line with sector
Dividend Yield
2.2%
Near historic low
Near historic low — last 10 years
Sector median 1.8%above sector
PEG ratio
2.7
Above average
Pricier than usual over the last 10 years
Sector median 1.8above sector
FCF Yield
4.1%
Near historic low
Near historic low — last 10 years
Sector median -12.6%above sector
Free · No credit card needed

Get alerted when AMGN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.